Worldwide Heart Valve Market Report: 2010 Edition
The heart valve market is growing at a single digit rate. During the period 2001-2009, the market has grown at a CAGR of nearly seven percent. Among the three distinct segments, i.e. tissue valve, mechanical valve and valve repair market, tissue valve represent the largest part of the heart valve market with a share of more than fifty percent of the total heart valve market. The heart valve repair market represents the smallest of the three segments.
The demand of mechanical valves is declining slowly with a continuous shift towards tissue valves. However, the shift towards tissue market is slow as there is still an appropriate pool of mechanical valve patients, who are mainly younger patients who would outlive the life cycle of a tissue valve.
A new market has emerged in last few years named as transcatheter valve market which has a huge amount of untapped potential. Transcatheter valves represent an attractive market opportunity as the technology could expand the overall heart valve market and provide higher risk patients with a less invasive approach. The penetration of worldwide risk/refused for surgery population was just five percent in 2009, and is expected to exceed thirty percent by the end of 2015.
The growing aging population, increased consumption of junk food, increasing cases of obesity, and rising urban population are few of the factors which are significantly driving the global heart valve market growth. The industry players are seeking opportunities in the regions with higher prevalence of these factors to increase their market presence.
The primary competitors in heart valve market include Edwards Lifesciences, St. Jude Medical, Inc., Medtronic, Inc. and Sorin Group. The global tissue valve market is dominated by Edwards Life Sciences, while St. Jude Medical is the global market leader in the mechanical valve segment.
The report provides an analysis of the global heart valve market. It also discusses major trends, growth drivers and potential markets for heart valve market. The report also presents the competitive structure of the industry and profiles major players in the market with a discussion of their key business strategies.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
The demand of mechanical valves is declining slowly with a continuous shift towards tissue valves. However, the shift towards tissue market is slow as there is still an appropriate pool of mechanical valve patients, who are mainly younger patients who would outlive the life cycle of a tissue valve.
A new market has emerged in last few years named as transcatheter valve market which has a huge amount of untapped potential. Transcatheter valves represent an attractive market opportunity as the technology could expand the overall heart valve market and provide higher risk patients with a less invasive approach. The penetration of worldwide risk/refused for surgery population was just five percent in 2009, and is expected to exceed thirty percent by the end of 2015.
The growing aging population, increased consumption of junk food, increasing cases of obesity, and rising urban population are few of the factors which are significantly driving the global heart valve market growth. The industry players are seeking opportunities in the regions with higher prevalence of these factors to increase their market presence.
The primary competitors in heart valve market include Edwards Lifesciences, St. Jude Medical, Inc., Medtronic, Inc. and Sorin Group. The global tissue valve market is dominated by Edwards Life Sciences, while St. Jude Medical is the global market leader in the mechanical valve segment.
The report provides an analysis of the global heart valve market. It also discusses major trends, growth drivers and potential markets for heart valve market. The report also presents the competitive structure of the industry and profiles major players in the market with a discussion of their key business strategies.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
1. HEART VALVES: AN OVERVIEW
2. GLOBAL HEART VALVE MARKET
Market Value
Market Segmentation
Market Share – Overall & By Segments
3. EMERGING TRANSCATHETER VALVE MARKET
3.1 Market Size
3.2 Market Potential
3.2.1 Market Opportunity in the United States
3.2.2 High Anticipated Penetration in Europe
4. MARKET TRENDS
4.1 Patients Profile for Aortic Stenosis
4.2. Mitral Regurgitation (MR)
5. KEY GROWTH DRIVERS
5.1. Increasing Aging Population
5.2 Rising Number of Obesity Cases
5.3 Rising Urban Population
5.4 Rising Consumer Income
6. COMPANY PROFILES
6.1 Medtronic
Overview
Key Financials
Business Strategies
Acquisitions, Investments & Alliances
Sales & Marketing Strategy
6.2 St. Jude Medical
Overview
Key Financials
Business Strategies
Increasing Worldwide CRM Market Share
Focus On Improving Operating Margin
6.3 Edwards Lifesciences
Overview
Key Financials
Business Strategies
Leadership Position in Transcatheter Valve
6.4 Sorin Group
Overview
Key Financials
Business Strategies
Expanding Geographic Reach
Driving Innovation
7. INDUSTRY OUTLOOK
7.1 Market Forecast
7.2 Forecast Methodology
7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis
2. GLOBAL HEART VALVE MARKET
Market Value
Market Segmentation
Market Share – Overall & By Segments
3. EMERGING TRANSCATHETER VALVE MARKET
3.1 Market Size
3.2 Market Potential
3.2.1 Market Opportunity in the United States
3.2.2 High Anticipated Penetration in Europe
4. MARKET TRENDS
4.1 Patients Profile for Aortic Stenosis
4.2. Mitral Regurgitation (MR)
5. KEY GROWTH DRIVERS
5.1. Increasing Aging Population
5.2 Rising Number of Obesity Cases
5.3 Rising Urban Population
5.4 Rising Consumer Income
6. COMPANY PROFILES
6.1 Medtronic
Overview
Key Financials
Business Strategies
Acquisitions, Investments & Alliances
Sales & Marketing Strategy
6.2 St. Jude Medical
Overview
Key Financials
Business Strategies
Increasing Worldwide CRM Market Share
Focus On Improving Operating Margin
6.3 Edwards Lifesciences
Overview
Key Financials
Business Strategies
Leadership Position in Transcatheter Valve
6.4 Sorin Group
Overview
Key Financials
Business Strategies
Expanding Geographic Reach
Driving Innovation
7. INDUSTRY OUTLOOK
7.1 Market Forecast
7.2 Forecast Methodology
7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis
LIST OF CHARTS
Heart Valve Market Segmentation
Global Heart Valve Market by Value, 2001-2009
Global Heart Valve Market Sales by Segments, 2001-2009
Global Heart Valve Market Share by Segments, 2009E
Global Heart Valve Market Share, 2006-20010E
Global Tissue Heart Valve Market Share, 2009E
Global Mechanical Heart Valve Market Share, 2009E
Global Heart Valve Repair Market Share, 2009E
Global Transcatheter Valve Market, 2008-2015F
Major Causes of Left-sided Valve Disease
Prevalence of Aortic Stenosis Stratified By Age
Overall Mitral Regurgitation Prevalence
Prevalence of Mitral Regurgitation Stratified by Age and Gender
Population Over 65 Years of Age (%): Actual & Estimated (1960 - 2030)
Global Obesity Forecast of World Population (Billion): (2005 – 2015E)
Global Urban Population by Geography (%): (2004-2008)
World Gross National Income Per Capita (US$) by Category, 2001-2008
World Gross National Income Per Capita (US$) by Region, 2001-2008
Medtronic Revenues Share by Segments, 2010
Medtronic Revenues Share by Geography, 2010
Heart Valve Market Forecast, 2010F-2012F
Heart Valve Market Segmentation
Global Heart Valve Market by Value, 2001-2009
Global Heart Valve Market Sales by Segments, 2001-2009
Global Heart Valve Market Share by Segments, 2009E
Global Heart Valve Market Share, 2006-20010E
Global Tissue Heart Valve Market Share, 2009E
Global Mechanical Heart Valve Market Share, 2009E
Global Heart Valve Repair Market Share, 2009E
Global Transcatheter Valve Market, 2008-2015F
Major Causes of Left-sided Valve Disease
Prevalence of Aortic Stenosis Stratified By Age
Overall Mitral Regurgitation Prevalence
Prevalence of Mitral Regurgitation Stratified by Age and Gender
Population Over 65 Years of Age (%): Actual & Estimated (1960 - 2030)
Global Obesity Forecast of World Population (Billion): (2005 – 2015E)
Global Urban Population by Geography (%): (2004-2008)
World Gross National Income Per Capita (US$) by Category, 2001-2008
World Gross National Income Per Capita (US$) by Region, 2001-2008
Medtronic Revenues Share by Segments, 2010
Medtronic Revenues Share by Geography, 2010
Heart Valve Market Forecast, 2010F-2012F
LIST OF TABLES
US Total Heart Valve & TAVI Market Opportunity, 2011E-2015E
Anticipated Market Penetration in the United States, 2008-2015
Estimated European Populations of Valve Disease, 2009
Anticipated Market Penetration in European Union, 2008-2015E
St. Jude Revenues by Segments and Geography, 2009
Edwards Lifesciences Revenues by Segment and Geography, 2009
Sorin Revenues by Segments and Geography, 2009
Dependent & Independent Variables (2001– 2008)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
US Total Heart Valve & TAVI Market Opportunity, 2011E-2015E
Anticipated Market Penetration in the United States, 2008-2015
Estimated European Populations of Valve Disease, 2009
Anticipated Market Penetration in European Union, 2008-2015E
St. Jude Revenues by Segments and Geography, 2009
Edwards Lifesciences Revenues by Segment and Geography, 2009
Sorin Revenues by Segments and Geography, 2009
Dependent & Independent Variables (2001– 2008)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
